Literature DB >> 16849542

p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints.

Shulin Wang1, Wafik S El-Deiry.   

Abstract

Whereas the p53 tumor suppressor protein plays a central role in cellular checkpoints that respond to damage or stress to prevent tumorigenesis, the transcriptional control of the p53 gene has remained unclear. We show that chemotherapeutic agents induce p53 transcription and that p73 or p53 transactivates endogenous p53 expression through direct binding to the p53 promoter. Silencing of p53 or p73 by RNA interference significantly suppresses p53 transcription under physiologic conditions or in response to cellular stress. Mutational analysis of the human p53 promoter localized a p53 DNA-binding site, which confers p53- or p73-dependent p53 promoter activation. Importantly, impaired p53-mediated autoregulation of p53 transcription by inducible-interfering RNA results in aberrant cell cycle regulation and suppression of p53-mediated apoptosis. Thus, a positive feedback loop regulates human p53 expression and involves p73 and p53. Disruption of p53 transcription contributes to defective checkpoint control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849542     DOI: 10.1158/0008-5472.CAN-06-0511

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  Tied up in loops: positive and negative autoregulation of p53.

Authors:  Xin Lu
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

Review 3.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

4.  p53 prevents neurodegeneration by regulating synaptic genes.

Authors:  Paola Merlo; Bess Frost; Shouyong Peng; Yawei J Yang; Peter J Park; Mel Feany
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

5.  NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity.

Authors:  Nasir Haider; Previn Dutt; Bert van de Kooij; Jason Ho; Luis Palomero; Miquel Angel Pujana; Michael Yaffe; Vuk Stambolic
Journal:  Oncogene       Date:  2020-06-19       Impact factor: 9.867

6.  p53 is a direct transcriptional target of MYCN in neuroblastoma.

Authors:  Lindi Chen; Nunzio Iraci; Samuele Gherardi; Laura D Gamble; Katrina M Wood; Giovanni Perini; John Lunec; Deborah A Tweddle
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

Review 7.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

8.  Elevated expression of p53 in early colon polyps in a pig model of human familial adenomatous polyposis.

Authors:  Krzysztof Flisikowski; Marek Switonski; Agata Sikorska; Tatiana Flisikowska; Monika Stachowiak; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2018-08-25       Impact factor: 3.240

9.  Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells.

Authors:  Michelle Yan; Yang Song; Carmen P Wong; Karin Hardin; Emily Ho
Journal:  J Nutr       Date:  2008-04       Impact factor: 4.798

10.  Modeling the role of p53 pulses in DNA damage- induced cell death decision.

Authors:  Tingzhe Sun; Chun Chen; Yuanyuan Wu; Shuai Zhang; Jun Cui; Pingping Shen
Journal:  BMC Bioinformatics       Date:  2009-06-22       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.